Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC): a phase II prospective trial

BACKGROUND: The outcome of patients with muscle-invasive bladder cancer (MIBC) remains poor, despite aggressive treatments. Inadequate primary staging, classically performed by computed tomography (CT)-imaging, could lead to inappropriate treatment and might contribute to these poor results. Althoug...

Descripción completa

Detalles Bibliográficos
Autores principales: Verghote, Flor, Poppe, Lindsay, Verbeke, Sofie, Dirix, Piet, Albersen, Maarten, De Meerleer, Gert, Berghen, Charlien, Ost, Piet, Villeirs, Geert, De Visschere, Pieter, De Man, Kathia, De Maeseneer, Daan, Rottey, Sylvie, Van Praet, Charles, Decaestecker, Karel, Fonteyne, Valérie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522089/
https://www.ncbi.nlm.nih.gov/pubmed/34663254
http://dx.doi.org/10.1186/s12885-021-08861-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522089/
https://www.ncbi.nlm.nih.gov/pubmed/34663254
http://dx.doi.org/10.1186/s12885-021-08861-x

Ejemplares similares